Notable
SumMET · [225Ac]Ac-FL-261 · Solid Tumors Overexpressing c-MET
Recruitment opened
Full-Life Technologies UK LimitedPhase 1/2 NCT07873450 Registry history of NCT07873450 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Recruitment opened
Full-Life Technologies UK LimitedPhase 1/2 NCT07873450 Registry history of NCT07873450 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-14 | NCT07873450 SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET | Phase 1/2 | Recruiting |
| Phase 1 | 1 | |
| Phase 1/2 | 1 |
Cholangiocarcinoma (1) · Colorectal Cancer (1) · Head & Neck Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Prostate Cancer (1)